Premium
A. Case of Primary Non‐Hodgkin's Lymphoma of the Uterine Cervix Treated by Combination Chemotherapy (THP‐COP)
Author(s) -
Nasu Kaei,
Yoshimatsu Jun,
Urata Kenichiro,
Miyakawa Isao
Publication year - 1998
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/j.1447-0756.1998.tb00068.x
Subject(s) - medicine , pirarubicin , vincristine , cyclophosphamide , prednisolone , chemotherapy , gastroenterology , combination chemotherapy , lymphoma , non hodgkin's lymphoma , lactate dehydrogenase , cervix , gynecology , cancer , biochemistry , chemistry , enzyme
We present a case of primary non‐Hodgkin's lymphoma of the uterine cervix, Ann Arbor stage IE. This 64‐year‐old multiparous Japanese woman showed markedly elevated serum levels of lactate dehydrogenase (LDH) and of soluble interleukin‐2 receptor (sIL‐2R) at the time of diagnosis. Combination chemotherapy was administered and consisted of pirarubicin, cyclophosphamide, vincristine sulfate, and prednisolone (THP‐COP). After 3 courses of such therapy, the serum levels of LDH and of sIL‐2R decreased within normal limits, and the patient achieved a complete remission.